Insights

Strategic partnerships NashBio has a track record of collaborating with industry leaders (Illumina, Standigm, Verantos, Genuity Science) and is expanding through the Alliance for Genomic Discovery. This indicates strong potential to co-sell or white-label data products, attract co-development projects, and form strategic alliances with pharma, biotech, and diagnostics partners.

Clinical data expansion Recent launches such as Clinical Specialty offering and CS Oncology suggest NashBio is expanding its richly curated datasets to include deep phenotyping and specialty variables. This creates opportunities to upsell enhanced data assets and tailored data packages to oncology, rare disease, and other clinically focused R&D teams.

RWE and genomics emphasis NashBio combines real-world clinical, genomic, and imaging data with AI-enabled insights, aligning with demand for real-world evidence and genomics-based drug discovery. This positions NashBio well for contracts around RWE studies, patient trajectory analyses, and genomics-driven target identification.

Technology-enabled sales The tech stack includes HubSpot Analytics, Slack, WordPress and other modern tools, signaling mature marketing and customer collaboration capabilities. This supports scalable outbound outreach, targeted campaigns, and efficient onboarding for new clients across pharma, biotech, and medical devices.

Financial and scale signals With revenue in the 10–25 million range and a multi-partner ecosystem (VUMC backing, AGD members, industry collaborations), NashBio shows growth potential and credibility for larger enterprise deals. This suggests pursuing multi-year data access agreements, enterprise licensing, and expansion into additional therapeutic areas.

Similar companies to NashBio

NashBio Tech Stack

NashBio uses 8 technology products and services including HubSpot Analytics, Linkedin Insight Tag, WordPress, and more. Explore NashBio's tech stack below.

Media & News

NashBio's Email Address Formats

NashBio uses at least 5 email formats:
NashBio Email FormatsExamplePercentage
First@nashvillebiosciences.comJohn@nashvillebiosciences.com
78%
First.Last@nashvillebiosciences.comJohn.Doe@nashvillebiosciences.com
18%
FLast@nashvillebiosciences.comJDoe@nashvillebiosciences.com
4%
First@nashbio.comJohn@nashbio.com
50%
First.Last@nashbio.comJohn.Doe@nashbio.com
50%

Frequently Asked Questions

What is NashBio's phone number?

Minus sign iconPlus sign icon
You can contact NashBio's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NashBio's official website and social media links?

Minus sign iconPlus sign icon
NashBio's official website is nashbio.com and has social profiles on LinkedIn.

How much revenue does NashBio generate?

Minus sign iconPlus sign icon
As of October 2026, NashBio's annual revenue is estimated to be $10M - $25M.

What is NashBio's SIC code and NAICS code?

Minus sign iconPlus sign icon
NashBio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NashBio have currently?

Minus sign iconPlus sign icon
As of October 2026, NashBio has approximately 32 employees across 2 continents, including North America and Europe. Key team members include Business Director, Europe: G. H., Business Director Central Europe: D. A. G. and Business Director: K. D. C. Explore NashBio's employee directory with LeadIQ.

What industry does NashBio belong to?

Minus sign iconPlus sign icon
NashBio operates in the Biotechnology Research industry.

What technology does NashBio use?

Minus sign iconPlus sign icon
NashBio's tech stack includes HubSpot Analytics, Linkedin Insight Tag, WordPress, StackAdapt, Google Workspace, WP Engine, Slack and Vimeo.

What is NashBio's email format?

Minus sign iconPlus sign icon
NashBio's email format typically follows the pattern of First@nashvillebiosciences.com. Find more NashBio email formats with LeadIQ.

When was NashBio founded?

Minus sign iconPlus sign icon
NashBio was founded in 2018.
NashBio logo

NashBio

Biotechnology ResearchTennessee, United States11-50 Employees

NashBio is a biotechnology research company based in Nashville, Tennessee, operating as a for-profit subsidiary of Vanderbilt University Medical Center, and it was launched in 2018. It aims to make complex healthcare data usable by leveraging real-world clinical, genomic, and imaging data alongside bioinformatics tools to support the discovery and development of therapeutics and diagnostics. The company emphasizes deep, high-quality longitudinal datasets that are demographically diverse and clinically relevant, which are integrated and curated to facilitate customer use, and it serves clients in pharma, biotech, diagnostics, medical devices and other life sciences domains. In 2023, NashBio launched the Alliance for Genomic Discovery (AGD) in collaboration with Illumina and eight pharmaceutical companies to assemble a large collection of whole genome sequence data linked to de-identified medical records for drug discovery and development. NashBio is located at 2525 West End Avenue, Suite 930, Nashville, TN 37203, United States, and employs between 11 and 50 people.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    NashBio's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.